Consolidated Income Statement (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenues
Investment banking	$ 2,651	$ 1,644	$ 4,940	$ 3,355
Trading	6,723	4,745	13,453	9,856
Investments	226	388	372	757
Commissions and fees	1,833	1,425	3,523	2,906
Asset management	6,912	5,953	13,642	11,916
Other	223	290	515	1,041
Total non-interest revenues	18,568	14,445	36,445	29,831
Interest income	15,902	14,905	31,175	28,653
Interest expense	13,122	12,558	25,692	23,953
Net interest	2,780	2,347	5,483	4,700
Net revenues	21,348	16,792	41,928	34,531
Provision for credit losses	98	196	196	331
Non-interest expenses
Compensation and benefits	8,187	7,190	16,729	14,711
Brokerage, clearing and exchange fees	1,464	1,188	2,720	2,410
Information processing and communications	1,203	1,089	2,351	2,139
Professional services	680	711	1,282	1,385
Occupancy and equipment	482	459	965	908
Marketing and business development	401	297	711	535
Other	1,485	1,040	2,615	1,946
Total non-interest expenses	13,902	11,974	27,373	24,034
Income before provision for income taxes	7,348	4,622	14,359	10,166
Provision for income taxes	1,695	1,047	3,068	2,220
Net income	5,653	3,575	11,291	7,946
Net income applicable to noncontrolling interests	72	36	143	92
Net income applicable to Morgan Stanley	5,581	3,539	11,148	7,854
Preferred stock dividends	145	147	301	305
Earnings applicable to Morgan Stanley common shareholders	$ 5,436	$ 3,392	$ 10,847	$ 7,549
Earnings per common share
Basic (USD per share)	$ 3.50	$ 2.15	$ 6.96	$ 4.78
Diluted (USD per share)	$ 3.46	$ 2.13	$ 6.90	$ 4.73
Average common shares outstanding
Basic (shares)	1,554	1,577	1,558	1,581
Diluted (shares)	1,569	1,593	1,573	1,596

Consolidated Cash Flow Statement (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities
Net income	$ 11,291	$ 7,946
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Stock-based compensation expense	1,133	1,008
Depreciation and amortization	1,916	2,172
Provision for credit losses	196	331
Other operating adjustments	260	156
Changes in assets and liabilities:
Trading assets, net of Trading liabilities	(29,728)	(65,970)
Securities borrowed	(29,450)	(16,100)
Securities loaned	3,426	3,967
Customer and other receivables and other assets	(40,203)	(13,253)
Customer and other payables and other liabilities	56,924	36,316
Securities purchased under agreements to resell	(9,273)	11,810
Securities sold under agreements to repurchase	23,663	19,470
Net cash provided by (used for) operating activities	(9,845)	(12,147)
Proceeds from (payments for):
Other assets—Premises, equipment and software	(1,573)	(1,476)
Changes in loans, net	(21,138)	(18,186)
AFS securities:
Purchases	(16,668)	(18,687)
Proceeds from sales	6,878	2,462
Proceeds from paydowns and maturities	14,021	9,111
HTM securities:
Purchases	(1,294)	0
Proceeds from paydowns and maturities	6,901	4,520
Other investing activities	(931)	(450)
Net cash provided by (used for) investing activities	(13,804)	(22,706)
Net proceeds from (payments for):
Other secured financings	5,095	3,374
Deposits	30,977	13,232
Proceeds from issuance of Borrowings	99,444	69,341
Payments for:
Borrowings	(54,037)	(45,092)
Repurchases of common stock and employee tax withholdings	(4,547)	(3,159)
Cash dividends	(3,385)	(3,200)
Other financing activities	(27)	216
Net cash provided by (used for) financing activities	73,520	34,712
Effect of exchange rate changes on cash and cash equivalents	(1,431)	3,885
Net increase (decrease) in cash and cash equivalents	48,440	3,744
Cash and cash equivalents, at beginning of period	111,695	105,386
Cash and cash equivalents, at end of period	160,135	109,130
Supplemental Disclosure of Cash Flow Information
Cash payments for interest	26,585	24,543
Cash payments for income taxes, net of refunds	$ 2,171	$ 2,345

Consolidated Balance Sheet - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Assets
Cash and cash equivalents	$ 160,135	$ 111,695
Trading assets at fair value ($278,278 and $213,269 pledged as collateral)	544,153	428,276
Available-for-sale at fair value (amortized cost of $107,761 and $112,522)	105,532	110,466
Held-to-maturity (fair value of $40,238 and $45,615)	47,747	53,090
Securities purchased under agreements to resell (includes $109 and $— at fair value)	129,516	120,243
Securities borrowed	181,358	151,908
Customer and other receivables	151,010	114,720
Loans:
Held for investment (net of allowance for credit losses of $1,248 and $1,132)	289,318	268,720
Held for sale	13,057	9,374
Goodwill	17,105	16,726
Intangible assets (net of accumulated amortization of $2,042 and $1,882)	5,873	6,010
Other assets	30,253	29,042
Total assets	1,675,057	1,420,270
Liabilities
Deposits (includes $8,647 and $8,755 at fair value)	446,068	415,523
Trading liabilities at fair value	255,589	169,569
Securities sold under agreements to repurchase (includes $887 and $696 at fair value)	102,202	78,539
Securities loaned	20,736	17,310
Other secured financings (includes $19,461 and $16,871 at fair value)	29,819	21,603
Customer and other payables	279,070	226,519
Other liabilities and accrued expenses	31,577	29,620
Borrowings (includes $147,514 and $132,479 at fair value)	392,556	348,935
Total liabilities	1,557,617	1,307,618
Commitments and contingent liabilities (see Note 13)
Equity
Preferred stock	9,750	9,750
Common stock	20	20
Additional paid-in capital	31,597	31,153
Retained earnings	122,774	115,091
Employee stock trusts	5,912	5,154
Accumulated other comprehensive income (loss)	(6,329)	(6,285)
Common stock held in treasury at cost, $0.01 par value (466,962,871 and 456,059,842 shares)	(41,483)	(38,097)
Common stock issued to employee stock trusts	(5,912)	(5,154)
Total Morgan Stanley shareholders’ equity	116,329	111,632
Noncontrolling interests	1,111	1,020
Total equity	117,440	112,652
Total liabilities and equity	$ 1,675,057	$ 1,420,270